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                                  1. INTRODUCTION
Although over a century has elapsed since the first description of deleterious effects 
of radiation on normal tissues , such effects remain the principle limitation of radiotherapy. 
Although current powerful radiation sources could be effective in destroying most, if not 
all, tumors, no   ideal   method exists to deliver radiation to cancer exclusively and   spare 
normal   tissues. Radiation is used as part of treatment in more than half of all cancer 
patients . Incidence of severe radiation-related complications is difficult to determine, long 
periods of follow up are required. Local symptoms may be underestimated, because 
physicians and patients may be more concerned with metastatic disease or immediately life-
threatening conditions. Compared to studies that address the efficacy of radiotherapy, few 
studies exist in which complications are approached methodically and as the primary focus. 
Nevertheless, radiation damage to normal tissues can be costly and have not only a major 
impact on quality of life but also on overall survival.
Rather than discussing benefits of radiotherapy, this thesis article reviews radiation 
damage to normal tissues, including basic science aspects, and focuses on the most severe 
anorectal complications of radiotherapy. Recognition and treatment of associated lesions, 
including cancer recurrence, are crucial for obtaining satisfactory results.
Types and sources of radiation
Forms of radiation used clinically include X-rays, gamma (c)-rays, beta (b)-rays, and 
electrons . X-rays and c-rays are examples of electromagnetic radiation; b-rays and 
electrons are particulate radiation. As these forms of radiation interact with tissues, ionic 
radicals are released; Thus the term, `ionizing radiation.' Radiation is measured in Grays 
(Gy). One Gy is defined as the absorbed dose of energy per kilogram of soft tissue, and is 
equal to one Joule per kilogram. The rad was used previously, and corresponds to one 
centigray (100 rad. 1 Gy). External beam radiotherapy uses megavoltage photon irradiation 
delivered by Cobalt-60 (c-rays) sources or high-energy linear accelerators (X-rays). The 
latter have been preferred for abdomino-pelvic malignancies because of a potent effect on 
deep tissues with minimal skin toxicity. Brachytherapy uses sources adjacent (cavitary) or 
within (interstitial) tumors, which permits delivery of high doses of radiation to the area 
surrounding the source; e.g. up to 200 Gy can be delivered in endocavitary uterine 
brachytherapy (with a high risk of severe damage to surrounding tissues). Cesium-137, 
Iridium-192, Iodine-125, and Gold-198 are isotopes used commonly in brachytherapy. 1
Radiotherapy courses are combinations of dosage, length of time, and physics used. 
For most protocols in clinical use, these variables have been established empirically.
Dose fractionation and limited-field irradiation are techniques intended to minimize 
the risk of injury to normal tissues while maintaining a high likelihood of tumor control. 
Conformal techniques, which include cast-immobilization, tri-dimensional tumor definition, 
and individually defined radiation fields, also aim at reducing injury to normal tissues.
PATHOPHYSIOLOGY OF RADIATION DAMAGE
Radiation  damage  begins  with  disruptions  in  deoxyribonucleic  acid  (DNA)  and 
intracellular membranes. Subsequent changes in cells, tissues, and organs depend on the 
extent of those initial  molecular breaks and efficiency of cellular mechanisms of repair. 
Small DNA disruptions may be repaired readily, allowing the cell to maintain its function 
and ability to divide. Some of these breaks, however, may be sufficient to induce mutant 
genes. If such mutants are among cell cycle regulatory genes, for example, their expression 
may lead  to  long-term malignant  transformation.  Severe  damage to  the  DNA molecule 
results in immediate arrest of cell division, with cell death. In normal tissues, such extensive 
damage is manifested as depletion of an entire population of cells and long-term fibrotic 
changes2 .  Cells  that  sustain intermediate  degrees  of  DNA disruptions  may continue to 
divide temporarily, but mutations transmitted to their progeny eventually cause cell death.
Cells with short mitotic cycles, or undergoing active mitosis, are more likely to be 
damaged. `Acute reactants', such as intestinal mucosal cells are involved in acute, transient, 
radiation  toxicity  are  characterized  by high  proliferation  rates.  `Late  reactants',  such as 
endothelial  and smooth-muscle cells  involved in  chronic radiation injury divide slowly. 
Although the phase of the cell cycle can influence the response to irradiation, any cell, at 
any point in the cycle, can be damaged by high doses of radiation. Tissue damage correlates 
linearly with the total dose delivered; however, equal doses of radiation may have variable 
biological effects . Sensitivity to radiation is different for each cell type, tumor, or tissue. 
Conventionally, toxicity for each tissue is defined as minimal and maximal tolerance 
doses TD 5/5 and TD 50/5, which represent the dose that leads to complications in 5% and 
50% of patients within five years, respectively. The rectum, with TD 5/5 of 55 Gy and TD 
50/5 of 80 Gy, is more resistant to radiation than the colon and small bowel, both of which 
have TD 5/5 of 45 Gy and TD 50/5 of 65 Gy.2  
HISTOPATHOLOGY
Acute  toxicity  is  associated  with  a  variety  of  pathological  changes,  detectable 
predominantly  in  the  mucosa  of  irradiated  bowel.  The  epithelium  cannot  be  replaced 
adequately because of damage to progenitor cells; therefore, the mucosa becomes denuded 
within a few days after irradiation. Nuclear atypia, depletion of epithelial cells, bacterial 
invasion, vascular congestion, edema, and hemorrhage can be noted. Cellular changes may 
be  noted  in  crypts  of  the  colon  and  rectum,  and  include abnormal  mitotic  figures  and 
nuclear  fragmentation  of  epithelial  cells.  Inflammation  and  crypt  abscesses  also  occur, 
associated with neutrophilic infiltrates, mucosal congestion, and atrophy of villi3. Electron 
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Ulcerations  and  shallow  erosions  are  common  results  of  chronic  ischemia.  The 
columnar epithelium surrounding ulcerations is attenuated, and the crater characteristically 
contains  neutrophils,  lymphocytes,  plasma  cells,  histiocytes,  and  eosinophils  within 
granulation tissue. Erosion into vessels may result in gastrointestinal bleeding and anemia. 
Deep  fissures  and  ulcers  may  lead  to  perforation,  fistulization,  abscess,  or  peritonitis. 
Nonhealing  rectal  ulcers  are  usually  associated  with  extensive  areas  of  fibrosis.  Anal 
sphincter  biopsies  of  patients  with  anorectal  dysfunction  after  radiotherapy demonstrate 
damage to the myoenteric plexus and smooth-muscle hypertrophy 5.
The  fibrosis  after  bowel  irradiation  also  may  involve  the  submucosa,  muscular 
layers, and serosa. Of note, fibrotic reaction of tissues that surround the bowel may lead to 
formation of adhesions and intestinal obstruction.
As in  other  irradiated  tissues,  `radiation  fibroblasts'  may be  present  in  irradiated 
bowel.  These  cells  are  enlarged,  pleomorphic,  basophilic,  spindle-shaped,  and  may  be 
confused with  malignant  cells6.  Adipose  cells  also  may  be  seen  within  fibrous  tissues. 
`Colitis cystica profunda' is presence of cysts lined by colonic epithelium in the submucosa 
or  muscularis  propria.  Such  glandular  structures  within  the  bowel  wall  also  may  be 
confused with cancer.
Predisposing factors
Damage to normal tissues depends upon the radiation technique, dose, volume of 
irradiated  tissues,  and  patient  factors.  The  combination  of  external  irradiation  with  an 
intracavitary  source  usually  carries  a  higher  risk  compared  with  either  technique alone 
because of the additive effects7. Proximity of structures in the field, mucosal coverage, and 
anatomic fixation also are associated with increased susceptibility to injury. 
The likelihood of  radiation  damage may be  increased  by radiosensitiers,  such as 
Doxorubicin,  5-flurouracil,  and  oxygenation  .  Conversely,  agents  such  as  2-
mercaptopropionyl,  vitamin E, and glutamine,  appear to have radioprotectant properties. 
Adhesions from surgery or inflammatory disease predispose to damage the small bowel 
because of fixation .
However, inflammatory bowel disease itself does not appear to predispose the bowel 
wall to radiation injury. Chronic injury appears to develop more rapidly and be more severe 
in patients with diabetes and arteriosclerotic disease  8.  The combination of pre-operative 
radiation with total mesorectal excision for treatment of rectal cancer has been reported to 
result in high anastomotic leak and perineal wound infection rates.
CLINICAL CLASSIFICATION
Acute,  subacute,  and  chronic  radiation  injury  have  been  defined  arbitrarily  as 
occurring within one month, between one and three months, and more than three months 
after radiotherapy, respectively  9. The severity of damage has been further classified into 
grades of toxicity and scoring systems. These classifications aim at facilitating comparison 
of results from different studies. Toxicity criteria for combined-modality treatments have 
not yet been devised fully.
Radiation protocols causing anorectal damage
Cervico-uterine carcinoma is treated frequently with radiation. The combination of 
external beam and intracavitary sources is customary in advanced carcinoma of the cervix. 
Enteritis and recto-vaginal fistula are common complications . An analysis of 1801 patients 
treated  between  1962  and  1982  showed  a  progressive  rise  in  radiation-induced  bowel 
disorders,  including  rectovaginal  fistula;  late  complications  that  required  surgical 
consultation  occurred  in  4% of  patients10.  Another  study  reported  a  17% incidence  of 
moderate or severe complications in patients who underwent pre-operative brachytherapy in 
combination with external beam for carcinoma cervix 11. The sigmoid colon was involved 
most frequently, followed by the rectum and genitourinary organs. Analysis of a series of 
831 patients with cancer of the cervix showed a linear correlation between the incidence of 
small-bowel complications and doses of radiation delivered12 . Similar observations have 
been made in relation to colonic injury.
Radiation is a major treatment modality in patients with carcinoma of the vagina . In 
a report of 165 patients who received total doses of 80±120 Gy, rectovaginal or rectovesical 
fistulas developed in 4% of patients . The accepted TD 5/5 for ulceration of the vagina is 
approximately 90 Gy and for fistula formation, greater than 100 Gy ; however, a threshold 
dose of only 80 Gy has been reported for development of a rectovaginal fstula 13. Tumour 
stage and location in the vagina influence these variations.
Approximately 30% of prostate cancers are treated with radiotherapy. With external 
beam alone,  acute gastrointestinal  effects  occur in  30% to 40% of patients  and usually 
develop within four weeks of therapy. Diarrhea, rectal discomfort, and tenesmus lead to 
interruption of therapy in approximately 5% of patients. 14. Chronic complications diarrhoea, 
rectal ulcers, strictures, and fistula affect approximately 12% of patients and may lead to 
surgical intervention in 1% of patients .  Severe late complications were noted in 3% of 
patients in one study. 
DIAGNOSIS OF RADIATION DAMAGE
When radiation is given in sufficient amounts to kill a tumour, one can presuppose 
some degree of damage to normal tissues,  with variable clinical  significance.  The most 
frequent complications the colorectal  surgeon encounters are skin and wound problems, 
radiation  enteritis,  proctocolitis,  fistulization,  and  stenosis.  Late  manifestations  do  not 
correlate with the incidence of acute toxicity.
Acute dermatitis involving the perianal area, buttocks, vulva, and perineum may be 
asymptomatic or cause itching, burning, and pain. Examination discloses erythema, maculo-
papular changes, vesicles, or ulcerations.
Using approximately 5 ´ 2 Gy/week fractionation, erythema usually appears between 
the  third  and  fifth  weeks  of  treatment,  and  becomes  more  accentuated  and  painful 
thereafter. Associated oedema and moist desquamation may develop. Severe reactions are 
rare and characterized by ulceration, haemorrhage and necrosis. After healing occurs, the 
new skin is usually erythematous for several weeks, followed by hyperpigmentation that 
resolves over several months. 
Chronic radiodermatitis frequently causes sensation of dryness, but hyperesthesia and 
significant  pain also may occur.  Findings include hyperpigmentation or depigmentation, 
hyperkeratosis, epilation, atrophy, fibrosis, telangiectasis, oedema, ulceration, and necrosis. 
Squamous cell carcinoma may develop years later.15
Radionecrosis, involving the anodermis or entire anal canal, may develop within the 
first two weeks following irradiation for anorectal or, rarely, gynaecological malignancy. 
Patients may report pain, constipation, and rectal bleeding. Fever, and perianal and 
perineal necrosis and infection, may develop16. Examination under anaesthesia is required to 
determine extent of tissue damage. Oedema, sphincter spasm, and necrosis are common 
findings.
Acute  proctitis  most  often  causes  tenesmus  and  bloody  mucus  discharge. 
Proctosigmoidoscopy discloses oedema, inflammation, and friability of the mucosa. 
These  manifestations  tend  to  resolve  within  a  few  weeks,  as  in  acute  colitis  or 
enteritis.  If  the  proctitis  is  extensive,  one  should  seek  other  sites  of  injury (e.g.  in  the 
vagina, urethra, and bladder). Whether diarrhea is due to intestinal injury or impaired rectal 
function can be difficult to determine17. In radiation enteritis or colitis, contrast studies may 
show  non-specific  mucosal  changes,  areas  of  thickening  and  stenosis,  and  decreased 
peristalsis18
On endoscopy; the mucosa is pale and telangiectatic. In chronic proctitis, symptoms 
usually  begin  approximately  one  year  after  radiation,  and  can  range  from  mild  to 
disabling19.  Hemorrhage, ulceration, perforation, fistulization, and stenosis can occur. On 
proctosigmoidoscopy, the mucosa is pale, telangiectatic, and friable. In cases of rectal or 
anastomotic strictures, the first concern is to rule out tumour recurrence. Ulceration on the 
anterior wall of the rectum also may be difficult to distinguish from recurrent rectal cancer 
after low anterior resection or prostate cancer after prostatectomy. Biopsies and imaging 
studies are necessary. Barium enema may help define the severity and location of a stenotic 
2 sphincter defects.
In  the  differential  diagnosis  of  radiation-related  lesions,  tumor  recurrence  or 
radiation-induced  de-novo  neoplasia  should  be  ruled  out.  In  addition,  cytomegalovirus 
(CMV) coloproctitis, perianal herpetic eruptions, and bacterial infections that result from 
immunosuppression secondary to cancer or chemotherapy may occur in irradiated areas. 
The  role  of  these  infections  is  essential  to  determine  because  they  usually  respond  to 
specific therapy. Other important conditions that may be confused with radiation injury are 
Crohn's disease, atherosclerotic ischaemic colitis, tuberculosis, and lymphoma.
Given  the  disparity  between  acute  and  chronic  effects,  and  inability  to  predict 
eventual  manifestations  of  late  injury,  frequent  follow-up  visits  are  recommended. 
Surveillance  should  include  at  least  a  thorough  history,  routine  physical  examination, 
gynecological and rectal examinations, and proctosigmoidoscopy. Colonoscopy, imaging, 
biopsies, and microbiology are used selectively.
Endoscopy and barium enema should be performed with special caution because of 
increased  risk  of  iatrogenic  perforation  of  irradiated  areas.  Although histology is  often 
necessary  to  establish  the  diagnosis  with  certainty,  biopsies  also  must  be  taken  with 
particular caution. 
Newer  diagnostic  modalities  like  high-resolution  MRI,  Endosonography  and 
defecography can provide important imaging data for anorectal problems.
PREVENTION
Total protection of normal ano-rectal structures during radiotherapy remains elusive. 
No significant data exist to support the use of prophylactic medications. Hyperbaric oxygen 
has been used after radiotherapy as an attempt to reduce progression of radiation-induced 
lesions.  The use of a high proton energy source can prevent damage to the skin.  Strict 
compliance  with  current  radiotherapy  standards,  including  conformal  techniques, 
fractionation, and control of equipment, should help in decreasing the risk of complications 
24.  
Prevention of damage to the small bowel and sigmoid colon is achievable because 
such  structures  normally  are  mobile.  Several  methods  have  been  proposed,  including 
surgical  pexy  and  implantation  of  breast-type  or  balloontype  spacers.  Non-surgical 
approaches also have been shown to be effective: for example, the so-called `belly board', a 
mattress with a hole on which the patient's abdomen is placed (in the prone position), has 
been reported to reduce small-bowel injury25,26 . Effective prevention of radiation enteritis 
has been reported with the creation of an intra-abdominal sling using absorbable mesh  or 
peritoneum, as well as spacers.
Although such methods increase  the  risk  of  infection,  internal  hernias,  and other 
complications, their use has been advocated after radiation for abdominopelvic malignancy, 
in particular when radiation doses greater than 45 Gy are needed. Optimal candidates would 
be patients with high pelvic recurrence risk, residual disease after debulking surgery,  or 
those with unresectable tumour at the time of exploration26.
TREATMENT
In treating radiation-induced complications, conservative measures should always be 
considered  first.  Most  acute  effects  are  reversible  and  require  only  supportive  and 
symptomatic care, and less-severe forms of chronic injury also can be controlled effectively 
by medical intervention.
Dermatitis  with erythema and dry desquamation is  best  treated  by application of 
sulfadiazine  ointments.  Severe  chronic  dermatitis  can  be  kept  dry  with  eosin  solution. 
Symptoms  of  acute  proctitis  usually  respond  to  sitz  baths,  antidiarrheals,  and  steroid 
retention  enemas.  Mild  chronic  proctitis  may require  long-term low-residue diets,  stool 
softeners, and 5-aminosalicylic acid or sucralfate enemas 27,28 . Even in the presence of mild 
rectal bleeding, most patients can be treated conservatively. For example, in a series of 109 
patients who underwent I-125 brachytherapy for prostate cancer, with minimum dose at 
140±160 Gy, 19% developed persistent rectal bleeding. 
Resolution  of  bleeding  occurred  in  all  these  patients  with  steroid  enemas,  laser 
coagulation, or reassurance alone. 
Formalin therapy is a practical and effective method for treating radiation-induced 
cystitis and proctitis.
A prospective study showed that 80 ml of 4% formalin instilled into the rectum in 
20-ml aliquots had 100% initial success in stopping rectal bleeding, with a low recurrence 
rate 29. 
Another approach, laser coagulation, although more invasive and expensive, also is 
highly effective and has the advantage of being feasible during the diagnostic endoscopy30 . 
Non-operative  management  of  chronic  enteritis  comprises  low-residue  diets,  low fat  or 
lactose-free diets, and antidiarrheal and antispasmodic drugs.
Actinic ulcerations, because of their ischaemic component, react like arterial ulcers, 
and similar precautions are required. Ulcerated areas should be protected from additional 
injury. Correction of low-flow states such as heart failure or dehydration can increase tissue 
oxygenation and promote healing. Skin wounds should be kept clean to avoid secondary 
infection, and severe mucosal ulceration and fistulas may require diversion to heal. 
Many patients who receive radiotherapy are elderly, have diseases other than cancer, 
are malnourished, have organ dysfunction, and have had surgery or chemotherapy. Such 
medical  conditions  should  be  optimized.  Correction  of  anaemia,whether  by  iron 
supplements, transfusion, or erythropoietin,improves tissue oxygen delivery and improves 
the likelihood of healing. Diabetes control also may be beneficial. Drugs must be used with 
caution.  When prescribing narcotic,  analgesic and antiin flammatory agents,  kidney and 
liver functions should be monitored because cancer or side-effects of adjunctive treatment 
often affect these organs. Gastrointestinal toxicity of nonsteroidal anti-inflammatory drugs 
may be exacerbated due to mucosal fragility after chemotherapy; bleeding tends to be more 
serious in this setting.
Dementia,  depression,  or  high  doses  of  narcotics  may  lead  to  poor  compliance. 
Special care is recommended during application of enemas because radiation renders the 
rectum more susceptible to perforation. Overall, symptomatic control is achieved in most 
patients with medical treatment and reassurance.
Currently, a wide variety of pharmacological options, endoscopic cautery techniques 
and  surgical  procedures  have  been  proposed  for  the  treatment  of  chronic  radiation 
proctopathy31,37,38.  Although  these  have  been  proposed  primarily  as  treatment  for  rectal 
bleeding,  the  control  of  other  symptoms  has  been  noted  with  some  of  these  agents. 
Pharmacological options include 5-aminosalicylic acid preparations, corticosteroid enemas, 
sucralfate (oral, enemas), formalin, short chain fatty acid enemas, oestrogen/progesterone, 
hyperbaric  oxygen,  antioxidants,  sodium  pentosan  polysulphate  and  misoprostol  rectal 
suppositories.
Of these, sucralfate and formalin therapy appear to be effective for bleeding control. 
Misoprostol rectal suppositories and oral sucralfate may be useful in the prevention of acute 
and chronic symptoms of radiation proctopathy. 
Endoscopic cautery techniques have included the use of Nd:YAG laser and argon 
laser  for  coagulation of  bleeding neovascular  telangiectasias.  Argon plasma coagulation 
offers  a  safe  non-contact  method  of  delivering  haemostasis  which  has  proven  to  be 
particularly useful in targeting difficult to reach lesions tangentially. 
Surgery  is  generally  reserved  for  severe  refractory  cases  involving  ongoing 
haemorrhage, obstruction, stricture formation, fistulas and perforation. Given that formal 
randomized placebo-controlled studies are lacking for most treatments, the management of 
these patients is often challenging and unclear. Hence, there is a need for more research and 
education on radiation proctopathy.
Surgical treatment
Radionecrosis of the anal canal requires a diverting colostomy. If healing occurs, 
anal stricture usually ensues, which represents another challenge because most advanced 
techniques  are  not  suitable  for  irradiated  tissues.  As  no  safe  method  exists  to  restore 
sphincter function after radiation damage, the best option is to leave the stoma permanently. 
Most cases of proctitis respond to conservative management. A diverting stoma does 
not prevent progression of radiation damage in the defunctionalized segment. Proctectomy 
is  occasionally  indicated  in  cases  of  disabling  tenesmus,  blood  loss  refractory  to 
conservative treatment, perforation, stenosis with suspected malignancy, or fistula. Younger 
patients with normal sphincter function may benefit from a coloanal anastomosis. In elderly 
patients, a Hartmann's procedure is more appropriate, and should be preferred to APR to 
avoid perineal wound problems.32
Several  techniques  can  be  used in  rectal  stenosis,  including diverting  colostomy, 
Hartmann's  procedure,  APR, low-anterior  resection,  coloanal  anastomosis,  and Bricker's 
repair. Dilatation can be performed manually for segmental strictures within finger reach. 
For higher stenoses, a Hegar's dilator, Savary bougies, or endoscopic balloon dilatation may 
be adequate; however, these methods have high rates of restenosis, which requires repeated 
dilatations every three to four months, with an increasing risk of perforation. Other methods 
include transanal lysis with electrocautery, transanal proctoplasty, and endorectal use of a 
linear stapler for stricture of an end-to-side colo-rectal anastomosis. A diverting stoma is 
usually  required  for  acute  obstruction  or  in  debilitated  patients.  When  resection  is 
performed, sphincter-saving procedures tend to have poor results. The distal rectal stump 
may be relatively ischaemic after radiotherapy, and a high risk of leakage is expected with 
either stapled or hand-sewn anastomoses. A coloanal sleeve anastomosis can be used in 
select  patients,  but  those  with  anal  sphincter  impairmen  are  unlikely  to  benefit  .  This 
technique involves resection of the strictured segment, mucosectomy of the anal canal, and 
use of proximal healthy colon for anastomosis at the level or just above the dentate line. A 
protective  temporary  diverting  stoma  is  mandatory.  The  rarely  performed  Bricker  and 
Johnston repair involves a patch graft of proximal colon with anantimesenteric split, folded 
over to correct a linear stricture . Other than the authors' series of 26 patients, experience 
with this complicated technique,which appears to be associated with high morbidity, hasnot 
been  well  described  in  the  literature.  In  the  elderly  or  debilitated  patient  who  needs 
resection,  a  permanent  colostomy is  safer  than restoring bowel  continuity by anyof the 
above  methods.  Radiation-induced  fistulas  usually  require  surgical  intervention.  Direct 
suture, however, is not recommended.In high, small colovaginal or rectovaginal fistulas, a 
pedicle graft of greater omentum can be used . The fistula is excised, edges of the bowel 
and vagina are trimmed, and the omentum is mobilized on a pedicle based on the right or 
left gastroepiploic artery and placed between rectal wall and vagina . Another technique 
(Martius)  uses a bulbocavernous flap or labial fat pad to cover a rectovaginal fistula . The 
borders of the fistula are excised and rectal and vaginal walls separated widely. The rectal 
defect  is then closed transversely,  and the fat  and fibromuscular content of the labium 
mobilized into the fistula site through a subcutaneous tunnel. Vascular supply can be based 
on either the internal or external pudendal arteries. Success with this method was reported 
in  80% of  patients  .  Bricker's  operation  could  be  suitable  for  a  large  fistula  alone  or 
associated with rectal  stricture.  However,  a  diverting stoma is  required,  and the  results 
reported include a 50% morbidity rate and 73 satisfactory continence .The preferred option 
for large defects is a coloanal  anastomosis. Mobilizing the splenic flexure can facilitate 
bringing nonirradiated left colon down to the pelvis. In low strictures, the rectum can be 
excised totally, or its wall left in place with no attempts to free it from the vagina. The 
mucosa  is  excised  and  colon  threaded  through  the  rectal  muscular  tubular  wall  and 
anastomosed at the dentate line. The anastomosis is protected by a diverting stoma, which 
may be closed approximately three months later. Full continence is recovered by 75% of the 
patients within one year. Although pre-operative assessment of anal sphincter function is 
essential when considering this type of reconstruction , much controversy exists regarding 
the  accuracy  of  manometry,  defaecography,  and  digital  examination.  Radiation-induced 
colovesical fistulas are rare, and the same procedures described above may be used in their 
management. Although these fistulae usually require surgical treatment, urgent surgery is 
not needed unless recurrent cancer is present or cannot be excluded. When a Anorectal 
radiation   patient  does  well  after  spontaneous  drainage  of  a  paracolic  abscess  into  the 
bladder, operation can be postponed until the clinical status improves and local conditions 
are more favourable. Inability to rule out cancer is an indication for earlier intervention. 
Small-bowel fistulas ± the ileum involved most  frequently ± are often associated 
with radiation damage to the colon and rectum. Areas of radiation injury found in the small 
bowel  during  laparotomy for  other  reasons should be managed with caution.  Extensive 
adhesiolysis  is  best  avoided  because  the  intestine  is  poorly  vascularized  and  prone  to 
fistulization, even when it appears thickened. 
Malabsorption, secondary to extensive mucosal damage or multiple strictures, may 
be  worsened  after  intestinal  resection;  therefore,  only  necessary  resections  should  be 
performed, with liberal use of intestinal bypasses. 
In the irradiated pelvis, anastomotic leaks with signs of sepsis or abscess formation 
are usually treated with drainage and proximal diversion. If the patient is eligible for future 
reestablishment  of  the  continuity,  a  right  transverse  colostomy  or  loop  ileostomy  are 
preferable, to preserve the left colon and serve as protective stoma after reconstruction. For 
complete anastomotic disruption, Hartmann's procedure is the operation of choice. 
When rectal  cancer  is  treated  with pre-operative  irradiation,  a  diverting  stoma is 
recommended  for  patients  undergoing  sphincter-saving  resection  after  having  received 
more than 45 Gy in less than five weeks. Similarly, after irradiation and APR within a short 
interval, it has been recommended that the perineum not be closed primarily.
Conclusions
Anorectum  and  adjacent  structures  are  at  great  risk  of  injury  secondary  to 
radiotherapy, and no specific guidelines for treatment exist. Expertise in this complex area 
is difficult to achieve. Surveillance, early and precise diagnosis, and appropriate therapy are 
paramount  in  managing such complications.  Moreover,  the combined effects  of  cancer, 
chemotherapy,  radiotherapy,  and  associated  diseases  often  require  multidisciplinary 
involvement.
Radiation damage tends to be underestimated because subtle changes on the surface 
often represent major involvement of deeper structures; in particular, the microcirculation. 
Therefore,  investigation  should  not  be  limited  to  symptomatic  or  obvious  lesions. 
Knowledge of the dose, source, and technique used for radiotherapy may help estimate the 
extent of damage. Healing of a radiation-induced lesion may be incomplete, and recurrent 
lesions from radiation endarteritis  or  progression of associated disorders  can precipitate 
symptoms even in a previously stable area. 
Patients with pain, or who are noncooperative with examination for any other reason, 
should undergo examination  under  anaesthesia.  Despite  modern imaging,  differentiation 
between changes due to radiation, surgery, and tumor may be challenging. Invasive tests are 
associated with high complication rates. Pre-operative radiation for rectal cancer followed 
by colorectal or coloanal anastomosis is an indication for frequent follow ups, even in the 
presence of a protective stoma. 
Medical treatment is preferred and sufficient for most radiation-induced damage to 
normal  tissues.  Surgery  on  irradiated  areas  is  associated  with  increased  risk  of 
complications, which adds to the generally higher surgical risk of cancer patients. Quality 
of life can be improved significantly with less-invasive modalities; for example, laser and 
formalin therapy for rectal bleeding.                                                
Cervical Carcinoma 
Worldwide, invasive cervical cancer is the most common genital female malignancy 
and the second most common malignancy in women, after breast cancer. The estimated 
total number of new cases is 371,200 per year worldwide or 9.8% of all cancers in women. 
The disease is more common in economically disadvantaged developing countries, in which 
78% of worldwide cervical cancers occur. These account for 15% of all cancers in women. 
The associated lifetime risk in such countries is about 3%. 
Cancer of the uterine cervix is largely a preventable disease characterized by a long 
lead-time,  with  precancerous  lesions  gradually  progressing  through  recognizable  stages 
before developing into invasive disease. The disease process is almost certainly curable if it 
is identified prior to its progression to invasive cancer. However, invasive cervical cancer 
remains  a  disease of  significant  morbidity,  and it  is  a  major  cause  of  cancer  deaths  in 
women worldwide, although its incidence and mortality rates have declined substantially 
(particularly  in  countries  that  have  well-developed  screening  programs).  Cancer  of  the 
cervix in its  early stages is  readily managed with surgery.  Radiation or  chemoradiation 
therapies are reserved for high-risk early stages or advanced disease.
Human papilloma virus (HPV) is now recognized as the most important causative 
agent in cervical carcinogenesis. Cancer of the cervix typically originates from a dysplastic 
or  premalignant  lesion  previously  present  at  the  active  squamocolumnar  junction.  The 
transformation from mild dysplastic to invasive carcinoma generally occurs slowly within 
several  years,  although  the  rate  of  this  process  varies  widely.  The  types  include  the 
following: exophytic, nodular, infiltrative, and ulcerative.
The  main  pathways  for  the  spread  of  invasive  cervical  cancer  consist  of  the 
following: (1) microscopic spread into vaginal mucosa beyond visible or palpable tumor; 
(2) extension into the endometrium or myometrium of the corpus; (3) direct extension into 
the parametrium and in advanced stages into adjacent structures; and (4) spread into the 
regional pelvic lymph nodes and potentially into the retroperitoneal, inguinal, or thoracic 
lymph nodes. 
Squamous cell carcinoma (SCC) accounts for 80-90% of all cervical malignancies in 
large  series33.39.  The  major  histopathologic  subtypes  include  (1)  well-differentiated, 
keratinizing, large-cell SCC (25% of cases); (2) moderately differentiated, nonkeratinizing, 
large-cell SCC (70% of cases); and (3) small-cell undifferentiated carcinoma (about 5% of 
cases), which is associated with distinctly poor prognosis. 
Pure adenocarcinomas arise from endocervical type cells and constitute 5-20% of all 
cervical malignancies.
Prognosis
Among the major factors that influence prognosis are stage, volume and grade of 
tumor, histologic type, lymphatic spread, and vascular invasion
Stages are defined by the Federation Internationale de Gynecologie et d'Obstetrique 
(FIGO) or the American Joint Committee on Cancer's (AJCC) TNM classification
TNM definitions 
Primary tumor (T)
• TX: Primary tumor cannot be assessed 
• T0: No evidence of primary tumor 
• Tis: Carcinoma in situ 
• T1/I:  Cervical  carcinoma  confined  to  uterus  (extension  to  corpus  should  be 
disregarded) 
• T1a/IA: Invasive carcinoma diagnosed only by microscopy. 
• T1b/IB: All macroscopically visible lesions--even with superficial invasion. 
• T1a1/Ia1: Measured stromal invasion 3 mm or less in depth and 7 mm or less in 
horizontal spread 
• T1a2/IA2: Measured stromal invasion more than 3 mm and not more than 5 mm 
with a horizontal spread 7 mm or less 
• T1b/IB: Clinically visible lesion confined to the cervix or microscopic lesion 
greater than T1a2/IA2 
• T1b1/IB1: Clinically visible lesion 4 cm or less in greatest dimension 
• T1b2/IB2: Clinically visible lesion more than 4 cm in greatest dimension 
• T2/II: Cervical carcinoma invades beyond uterus but not to pelvic wall or to the 
lower third of the vagina 
• T2a/IIa: Tumor without parametrial involvement 
• T2b/IIb: Tumor with parametrial involvement 
• T3/III: Tumor extends to the pelvic wall and/or involves the lower third of the 
vagina, and/or causes hydronephrosis or nonfunctioning kidney 
• T3a/IIIA: Tumor involves lower third of the vagina, no extension to pelvic wall 
• T3b/IIIB: Tumor  extends  to  pelvic  wall  and/or  causes  hydronephrosis  or 
nonfunctioning kidney 
• T4/IVA: Tumor  invades  mucosa  of  the  bladder  or  rectum,  and/or  extends 
beyond true pelvis (bullous edema is not sufficient to classify a tumor as T4) 
• M1/IVB: Distant metastasis 
Regional lymph nodes (N) 
• NX: Regional lymph nodes cannot be assessed 
• N0: No regional lymph node metastasis 
• N1: Regional lymph node metastasis 
Distant metastasis (M) 
• MX: Distant metastasis cannot be assessed 
• M0: No distant metastasis 
• M1: Distant metastasis 
TREATMENT OVERVIEW
Stage 0
Methods to treat ectocervical lesions include: 
1. Loop electrosurgical excision procedure (LEEP). 
2. Laser therapy. 
3. Conization. 
4. Cryotherapy.
Total  abdominal  or  vaginal  hysterectomy  is  an  accepted  therapy  for  the  post 
reproductive age group and is particularly indicated when the neoplastic process extends to 
the inner cone margin
For medically inoperable patients, a single intracavitary insertion with tandem and 
ovoids for 5,000 milligram hours (8,000 cGy vaginal surface dose) may be used.
Stage 1
1. Radiation therapy: External-beam pelvic irradiation combined with 2 or more 
intracavitary applications
2. Radical hysterectomy and bilateral pelvic lymphadenectomy
Stage 2 A
Radiation  therapy:  Intracavitary  radiation  combined  with  external-beam  pelvic 
irradiation. Radiation to para-aortic nodes may be indicated in primary tumors 4 centimeters 
or larger
Radical hysterectomy and pelvic lymphadenectomy
Stage 2B
Radiation  therapy  plus  chemotherapy:  Intracavitary  radiation  and  external-beam 
pelvic irradiation combined with cisplatin or cisplatin/fluorouracil
Stage III
Radiation  therapy  plus  chemotherapy:  Intracavitary  radiation  and  external-beam 
pelvic irradiation combined with cisplatin or cisplatin/fluorouracil
Stage IV
Radiation  therapy  plus  chemotherapy:  Intracavitary  radiation  and  external-beam 
pelvic irradiation combined with cisplatin or cisplatin/fluorouracil.
2.  BACKGROUND
Cancer cervix is the most common type of cancer in Indian women and can cause 
significant morbidity and mortality. With the wide spread use of screening programs the 
incidence of advanced carcinoma in reduced, though we still could find large number of 
patients are being referred to tertiary medical care facility with advanced lesions.
One of the acknowledged treatment options for fairly advanced ca cervix beyond 
stage II A is radiotherapy (external beam as well as intracavity radiation).
We  see  lot  of  patients  being  referred  to  medical  gastroenterology  department  of 
Government General Hospital, Park Town Chennai with symptoms suggestive of radiation 
induced proctocolitis. 
Though the diagnosis of radiation induced proctocolitis is fairly easy and straight 
forward, the treatment is often elusive leaving the patients with considerable morbidity and 
reduced quality of life.
The most important issue is the risk of malignancy in the radiated tissues of rectum 
and sigmiod colon which appears to be substantial.
We undertook this study to identify the risk factors ( patients factors, disease factors, 
treatment regimen factors) for severity of bowel lesions. Also we tried to correlate clinically 
the risk of severe RPC to endoscopic severity. The biopsy specimen which was taken in 
suspicious sites were analysed for evidence of malignancy and to rule out other causes of 
rectal involvement.
3.   AIM OF THE STUDY
1. Identification  of  risk  factors  in  severe  radiation  induced  proctocolitis  in 
patients treated for advanced Ca cervix by radiotherapy.
2. To correlate the identified risk factors with that of endoscopic severity.
3. To  find  out  the  occurrence  of  adenocarcinoma  of  rectum and  distal  large 
bowel in patients who has radiation proctocolitis.
4.  MATERIALS AND METHODS
We retrospectively analysed 73 patients who presented with rectal bleeding along 
with other symptoms at least six weeks after radiotherapy for Ca Cervix.
Study type Retrospective analytical study
Study period June 2003 to July 2005 (25 months)
Venue Government General Hospital, Chennai
PROTOCOL
Inclusion criteria 
Patients with Ca cervix who had radiotherapy (external , Internal or both) presenting 
after 6 weeks with following symptoms
Rectal bleed
Mucus diarrhea
Tenesmus
Lower abdominal pain
Constipation
Exclusion criteria
Patients presenting less than 6 weeks with above symptoms Infectious diarrhea (as 
ruled out by stool examination and culture).
Intrinsic diseases of ano-rectum and sigmoid colon including hemorrhoids, fissure in 
ano, solitary rectal ulcer, IBD and malignancy ( by colonoscopy and HPE).
All the patients were admitted . Complete history including co morbid illness and 
thorough physical examination were done in all patients Routine blood, urine, motion 
examination,  ECG, CXR, USG abdomen were done.
Once stabilized elective colonoscopy was done in all. Colonoscopy was done with 
Pentax fibro optic colonoscope. 
Bowel preparation was done as follows Clear liquids, tender coconut water and soft 
drinks were permitted the previous day (24 hours). Two tablets of bisacodyl were given the 
previous night.  On the day of the procedure one sachet of PEGLEC was mixed with two 
litres of water and taken in sips for two hours.
Colonoscopy was done by experienced endoscopists and findings recorded. Biopsy 
was taken if found necessary. 
5.  RESULTS
Total  patients    - 73
All are females
Age distribution 
39.7% of  cases  belonged  to  age  group  of  more  than  50  years  while  13% were 
between 31 – 40 years.
Symptoms
It is noted that the predominant symptom was bleeding per rectum (100%), tenesmus 
(1.4%) mucus diarrhea (2%), constipation (4.1%), pain abdomen (13.5%) were also seen in 
increasing frequency.
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Comorbid illness 
Various comorbid illness were noted in these patients who had radiotherapy. The 
break up was as follows. Diabetes was seen in 10 cases, atherosclerotic disease in 2 cases , 
obesity in 2 cases.
Radiation dose
Most patients who received radiation come in middle radiation dosage (4500 rads to 
5000 rads) (89%). Only one patient exceeded dose of 5000 rads (1 case).
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Colonoscopy findings 
Most  common  lesion  identified  was  erythema  and  erosion  which  comprised  of 
45.2%. other findings included telengectasia (12.5%), superficial ulcers 17.8%, deep ulcers 
2.7%, friability in 4.1%, stricture in 2 cases and fistula in 4 cases (5.5%).
Biopsy and histopathology
Biopsy was done in all cases. All the specimen had significant findings. The common 
findings in HPE are as follows.
Mucosal ulceration 45%
Submucosal fibrosis      23%
Cellular infiltration        45%
Obliteration of vessels in submucosa 25%
Malignancy 
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After careful histopthology examination of the samples no dysplasia or malignant 
changes were noted (0%).
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6.  DISCUSSION
We analysed 73 patients with radiation induced mucosal damage and tried to identify 
the risk factors in the causation.
Age correlated significantly with the severity of symptoms. Patients who fall in the 
third  group  >  50  years  have  high  incidence  of  severe  symptoms.  But  it  did  not  have 
significant implication on the extent of lesion or the colonoscopic severity.
Duration of symptoms is also an important factor identified. Those patients who are 
symptomatic  for  >  2  years  have  severe  lesions  on  colonoscopy.  This  finding  may  be 
attributed to spontaneous healing within 6 months in milder forms of injury as described by 
various authors.
Gehrig J et al in his study has shown that age and mean duration of illness strongly 
predicted severe damage34.  Williams HRT et al has also shown similar results but in his 
study presence and severity of rectal bleeding was the best predictor.
Total radiation dose when exceeded 5000 rads caused severe disease. It  has good 
correlation with the extent of lesion, severity of lesion by colonoscopy. 
Clark BG,Souhami L et has shown that the total radiation dose and the  reference 
point  from  rectal  reference  point  (arbitrary  point  which  recieves  maximum  radiation 
exposure) influences the patient outcomes. Similar  study by  Dinakaran et al also confided 
with the same findings.
Intracavity radiation (brachytherapy) correlates well  with extent  of  lesion35.  More 
proximity to sigmoid and less protection to the mucosa may be implicated as the causative 
factor.  Yalman D et al in his article has described that intracavity radiation accounted for 
more extensive disease and more morbidity.
Low BMI  when combined with atherosclerotic disease causes severe lesions and 
more extensive lesion.
Diabetes and low Hb% in the setting of brachytherapy cause extensive damage and 
fistulization.
This finding confides with various authors but Gehrig J, Hacki WH  did not find any 
correlation  with  co-morbid  illness  like  diabetes  and  hypertension.  BMI  was  however 
influential in determining the extent of illness.
Stage of the disease is also linked to severe disease probably because increased usage 
of  brachytherapy  was  seen  in  this  subset.  Patients  having   III  b  disease  when  having 
diabetes and atherosclerotic disease with brachytherapy have long duration of symptoms, 
fistulizing disease, strictures, and more than 12 cm lesion.
In our analysis of 73 patients biopsy was taken in 20 when the lesions have increased 
friability, nodularity and fistulization. None of the biopsy had any dysplasia or malignant 
cancer. Probably long term follow  may be necessary for identification of dysplasia and 
malignancy.
Risio M,  Coverlizza S et al have postulated that Late cytokinetic abnormalities in 
irradiated mucosa is a strong predictor of future carcinogenesis though the exact incidence 
of malignancy occuring in irradiated mucosa appears to be extremely low36.
Definitive indication favouring surveillance programs post radiotherapy cannot be 
advised at this stage.
7.   CONCLUSION
After the completion of the study the following facts were conceded.
1. The incidence and severity of radiation induced damage to colonic mucosa 
was influenced by patient factors : age, presence of co-morbidities, low BMI, 
anemia,  long  duration  of  symptoms,  disease  factors  :stage  III  b  disease, 
treatment factors : total radiation dose, brachytherapy.
2. The   clinical  assessment  of  patients  with  the  above  risk  factors  is  strong 
predictor of severe lesions at colonoscopy
3. The risk of malignancy after radiation therapy in the affected colonic mucosa 
in extremely rare and routine surveillance for the detection of the same is not 
required.
8. BIBILOGRAPHY
1. Khan FM: The physics of radiation therapy. In: Interaction of Ionizing Radiation. 
Baltimore, Williams & Wilkins, 1994, p 79.
2. Leadon SA: Repair of DNA damage produced by ionizing radiation: a minireview. 
Semin Radiat Oncol 6:295, 1996.
3. Haboubi N, Schofield P, Rowland P. The light and electron microscopic features of 
early and late phase radiation induced proctitis. Am J Gastroenterol 1988;83:1140–4.
4. Hovdenak  N,  Fajardo  L,  Hauer-Jensen  M.  Acute  radiation proctitis:  a  sequential 
clinicopathologic study during pelvic radiotherapy. Int J Rad Oncol Biol Phys 2000.
5. Claben  J,  Belka  C,  Paulsen  F,  et  al:  Radiation  induced  gastrointestinal  toxicity. 
Strahlenther Onkol 174:82, 1998.
6. Rodier JF:Radiation enteropathy—incidence, aetiology, risk factors, pathology and 
symptoms. Tumori 81:122, 1995.
7. Andre dubois, radiation injury to gut section 10, chapter 86, page 1672 – 1682, 5th 
Edition, Bockus Gastroenterology, 1992 william S. Haubrich, Fenton schaffner MD.
8. Kochlar, Patel, Radiation induced procto sigmoiditis, digestive, diseases, 36, 1991, 
103 – 107.
9. Babb RR, Radiation Proctitis, a review American journal of GE, 1996 91, 1309 – 
1311.
10. Charles M. Rosen,  Kaner,  P 711 – 713, 1999,  Volume – I,  Clinical   Practice of 
gastroenterology, Lawrence J. Brandt, MD
1.1 J.C.H. cheng, proximal rectal dose in late rectal complication of Ca Cx with high 
dose brachy therapy, page 1010, Volume – 57 No 4 international journal of radiation 
oncology, biology & physics, November 15 2003.
12. Coucke PA, Maingon P, Ciernik IF,  et  al:  A survey on staging and treatment in 
uterine cervical carcinoma in the Radiotherapy Cooperative Group of the European 
Organization for Research and Treatment of Cancer. Radiother Oncol 54:221, 2000.
13. Lanciano & associates Mallinckrodt institute of radiology, Page 1794 – 1800, carlos. 
A perez, 4th edition, principles& practice of radiation oncology.
14. Yeoh,  etal,  Pelvic  irradiation  on  gastrointestinal  function  –  longitudinal  study 
American. Journal of medicine 1993, 95 – 397.
15. Roswit B. Complications of radiation therapy: the alimentary tract. Roentgenology 
1974;9:51.
16. Wellwood JM, Jackson BT. The intestinal complications of radiotherapy. Br J Surg 
1973;60:814. 
17. Danielson  A,  Chronic  diarrhea  after  radio  therapy  for  gynaecological  cancer, 
occurrence and etiology, Gut, 1991, 32, 1180.
18. Taylor  M,  Johnson,  Radiological  Changes  in  radiotherapy  for  CACX,  clinical 
radiology 1990, 41 , 165 – 169.
19 Silversteain, Tytgat, Atlas of G.I. Endo Scopy, New York, 1987 P 11 – 25, 11 – 26.
20. Gilinsky, burns, the natural history of radiation induced procto sigmoiditis, quarterly 
journal of medicine, 1983, 52, 42 – 53.
21. Shingleton, Kim 1956 – 1959, Ca Cx treatment, clinical oncology, 2nd edition martin 
– D – Abeloff, James O Armitage.
22.  Hellman S. (1993 4th edition) Principles of radiation therapy. In: Cancer: Principles 
and  Practice  of  Oncology  (eds  DeVita  VT,  Hellman  S  and  Rosenberg  SA),  pp. 
248±75.JB Lippincott Co, Philadelphia.
23. Babb RR, Radiation Proctitis, a review American journal of GE, 1996 91, 1309 – 
1311.
24. Brown JM. Sensitizers and protectors in radiotherapy. Cancer 1985; 55:2222. 
25. Waddell BE, Rodriguez MA, Lee RJ, et al: Prevention of chronic radiation enteritis. 
J Am Coll Surg 189:611, 1999.
26. Tony.  Y,  Eng  M.D,  San  Antonio,  Rectal  dose  reduction  Via  utilization  of  foley 
balloon catheter in high dose tandem & ovoid intra cavitory brachy therapy for Ca 
Cx Vol – 51, May 2004, Int. Journal of radiation oncology. 
27. Henriksson R, Franzen L, Littbrand B. Effects of sucralfate on acute and late bowel 
discomfort following radiotherapy of pelvic cancer. J Clin Oncol 1992;10:969.
28. Charneau  J,  Bouachour  G,  Person  B.  Severe  hemorrhagic  radiation  proctitis 
advancing to gradual cessation with hyperbaric oxygen. Dig Dis Sci 1991;36:373. 
29. Mathai V, Seow-Choen F. Endoluminal formalin therapy for haemorrhagic radiation 
proctitis. Br J Surg 1995;82:190. 
30. Taylor JG, Disario JA, Buchi KN. Argon laser therapy for hemorrhagic radiation 
proctitis long term results. Gastrointest Endosc 1993;39:641. 
31. Viggiano  TR,  Zieghelboim  J,  Ahlquist  DA,  et  al.  Endoscopic  nd:  YAG  laser 
coagulation  of  bleeding  from  radiation  proctopathy.  Gastrointest  Endosc 
1993;39:513. 
32. Jensen DM, Machicado GA, Cheng S,  et  al.  A randomized prospective  study of 
endoscopic bipolar electrocoagulation and heater probe treatment of chronic rectal 
bleeding from radiation telangiectasia. Gastrointest Endosc 1997;45:20.
33. Marks G, Mohiudden M. The surgical  management of radiation injured intestine. 
Surg Clin North Am 1983;63.
34. Shingleton, Kim 1956 – 1959, Ca Cx treatment, clinical oncology, 2nd edition martin 
– D – Abeloff, James O Armitage.
35. Gehrig J,  Hacki WH,  1987 Sep 5;117(36):1326-32  Current therapeutic options for 
radiation  proctopathy Hong  JJ,  Park  W,Ehrenpreis  ED Aliment  Pharmacol  Ther 
2001; 15(9): 1253-62
36. Radiation Proctocolitis,  varying clinical presentation & Endoscopic Presentation – 
our experience, Prof. N. Dinakaran, M.D., D.M., Indian Journal of Gastroenterology, 
ISGCON 2003 & 2004.
37. Risio M, Coverlizza S Late cytokinetic abnormalities in irradiated rectal mucosa,  Int 
J Colorectal Dis. 1990 May;5(2):98-102
38. Nostrant T.  Radiation injury. In: Yamada T, Alpers D, Owyang C,  et al,  eds. In: 
Textbook of gastroenterology, 3rd edn. Philadelphia: JB Lippencott, 2000:2605–16.
39. Nam. P. Nguyen & John E Antonie, P. 1994 – 2003, Chapter 102, Gastro Intestinal 
& Liver Disease, 7th Edition Mark Field Man, S Fried Man, Sleisenger M.D, Volume 
– II
40. Hellman S. (1993 4th edition) Principles of radiation therapy. In: Cancer: Principles 
and  Practice  of  Oncology  (eds  DeVita  VT,  Hellman  S  and  Rosenberg  SA),  pp. 
248±75. 
